Comfort of Patients Under Non Invasive Ventilation According to the Mask
NCT ID: NCT06212180
Last Updated: 2024-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
80 participants
OBSERVATIONAL
2024-01-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Feasibility Study Evaluating the Use of a Non-invasive Ventilation Mask
NCT02383719
NIV Mask Assessment of Usability and Performance
NCT05059288
Physiology of Helmet vs. Facemask Noninvasive Ventilation
NCT06210386
CPAP Therapy Through a Helmet or a Full Face Mask in Patients With Acute Hypoxemic Respiratory Failure: Cross-over Study
NCT06113432
Customized Masks in Non-Invasive Mechanical Ventilation
NCT06215391
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mask
patients will be their own comparator. Patients will try both mask for 10 min and then decide which mask they want for the rest of the ventilation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* COPD exacerbation
* Hydrostatic acute pulmonary edema
* Acute Chest Syndrome with Hypercapnia in Sickle Cell Patients
* Post-extubation, planned in a patient at risk or recovering from extubation failure
* Hypoventilation-obesity syndrome
Exclusion Criteria
* Indication for orotracheal intubation at the outset
* Non-cooperative, agitated, opponent of the technique
* Coma
* Respiratory exhaustion
* Shock, severe ventricular arrhythmias, immediate aftermath of cardiac arrest
* Undrained pneumothorax, blowing chest wound
* Upper airway obstruction (except sleep apnea, laryngotracheomalacia)
* Uncontrollable vomiting
* Upper gastrointestinal bleeding
* Measure of protection of justice
* Facial deformity
* Dying or palliative care patient
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christophe CARPENTIER, MD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris, Hôpital Bicêtre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Henri Mondor - Réanimation/ Unité de Surveillance Continue
Créteil, , France
CHU Bicêtre - Unité de Soins Intensifs Pneumologique
Le Kremlin-Bicêtre, , France
CHU Bicêtre - USC
Le Kremlin-Bicêtre, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Armand Mekontso Dessap, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A02093-42
Identifier Type: OTHER
Identifier Source: secondary_id
APHP231673
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.